Central Louisiana News

Congresswoman Julia Letlow, Congresswoman Annie Kuster, and Congressman Troy Balderson have joined forces to introduce bipartisan legislation aimed at combating the opioid epidemic and reducing prescription drug misuse. The Electronic Prescribing for Controlled Substances Act would mandate electronic prescriptions for all Schedule II-IV controlled substances, including opioids. This move is intended to enhance patient safety and deter fraud associated with these highly addictive medications.

In a statement, Congresswoman Julia Letlow emphasized the importance of taking proactive measures to address the opioid crisis, stating, “The deadly opioid epidemic has affected every community across the country – In order to curb opioid misuse and addiction we must take every step forward to save lives.” Letlow further explained that the Electronic Prescribing of Controlled Substances 2.0 Act (EPCS 2.0) would enable prescribers to electronically transmit accurate and error-free prescriptions directly to pharmacies, enhancing care quality and reducing the risk of drug addiction.

Congresswoman Annie Kuster underscored the necessity of preventing prescription fraud and abuse in combating the opioid epidemic, stating, “Electronic prescribing is a proven way to increase patient safety and ensure controlled substances, like highly addictive opioids, are prescribed and taken responsibly.” Kuster expressed pride in introducing legislation that addresses prescription misuse and supports healthcare providers in delivering safe and secure patient care.

Congressman Troy Balderson reiterated the urgency of combating prescription opioid abuse, emphasizing that the Electronic Prescribing for Controlled Substances Act represents a crucial step in the battle against opioid misuse. Balderson highlighted that by mandating electronic prescriptions for controlled substances, including opioids, the legislation enhances patient safety, streamlines the prescription process, and implements safeguards against abuse.

The Electronic Prescribing for Controlled Substances Act (EPCS 2.0) extends the requirement for Medicare providers to utilize electronic prescriptions for Schedule II-IV controlled substances to private insurers. The legislation also includes provisions for patients to select their preferred pharmacies and offers exceptions for pharmacies facing challenges in accessing the internet or technology.

The introduction of this legislation reflects a collaborative effort to address the opioid epidemic comprehensively and prioritize the well-being of individuals affected by substance misuse.